US Stock MarketDetailed Quotes

JAGX Jaguar Health

Watchlist

0.1800
+0.0100+5.88%

Close Apr 26 16:00 ET

0.1822
+0.0022+1.22%

Post 19:59 ET

51.70MMarket Cap-100P/E (TTM)

Jaguar Health Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-0.42%-33.24M

-16.00%-7.45M

20.39%-6.79M

13.40%-9.06M

-29.24%-9.95M

5.34%-33.1M

28.02%-6.42M

9.57%-8.53M

-5.55%-10.46M

-14.71%-7.7M

Net income from continuing operations

14.68%-41.87M

-2.63%-9.15M

36.66%-7.99M

-28.95%-12.11M

30.47%-12.63M

6.70%-49.08M

37.76%-8.91M

-3.42%-12.61M

33.31%-9.39M

-51.25%-18.16M

Operating gains losses

-266.71%-3.65M

1,000.00%9K

-369,300.00%-3.69M

100.96%6K

-98.90%31K

-10.22%2.19M

---1K

--1K

-465.12%-628K

24.34%2.82M

Depreciation and amortization

4.19%2.39M

-1.83%591K

6.47%625K

-4.17%621K

21.10%551K

26.42%2.29M

25.94%602K

24.10%587K

50.35%648K

5.57%455K

Other non cash items

6.33%13.38M

-45.31%1.72M

124.06%7.09M

10.36%3.13M

-58.12%1.44M

142.55%12.58M

103.90%3.14M

159.69%3.16M

130.25%2.84M

187.40%3.44M

Change In working capital

-150.65%-11.1M

-43.51%-3.33M

-2,221.58%-5.6M

53.86%-2M

-107.28%-179K

-295.32%-4.43M

-220.59%-2.32M

63.54%-241K

-621.45%-4.33M

1,305.71%2.46M

-Change in receivables

170.78%298K

-1,145.16%-324K

28.16%-296K

-168.71%-112K

607.39%1.03M

-117.43%-421K

-49.18%31K

-120.92%-412K

-90.70%163K

85.15%-203K

-Change in inventory

-1.93%-2.17M

-91.49%-810K

-179.86%-115K

122.50%420K

-7,645.45%-1.66M

-0.28%-2.12M

-9.30%-423K

112.96%144K

-221.34%-1.87M

156.41%22K

-Change in prepaid assets

-221.22%-5.01M

-668.81%-2.39M

2,079.66%1.17M

-113.79%-3.63M

-131.56%-160K

-95.98%-1.56M

-154.28%-311K

44.34%-59K

-176.38%-1.7M

178.12%507K

-Change in payables and accrued expense

-802.95%-3.81M

112.22%288K

-2,475.19%-6.22M

207.68%1.44M

-68.54%682K

-83.02%542K

-208.32%-2.36M

118.32%262K

100.43%469K

-1.99%2.17M

-Change in other current assets

96.91%-17K

-99.64%3K

95.51%-4K

100.15%2K

-260.00%-18K

-34.80%-550K

289.89%845K

---89K

---1.3M

-127.78%-5K

-Change in other current liabilities

-25.08%-394K

9.62%-94K

-43.68%-125K

-28.42%-122K

-82.76%-53K

-1,557.89%-315K

-89.09%-104K

-611.76%-87K

-600.00%-95K

---29K

Cash from discontinued investing activities

Operating cash flow

-0.42%-33.24M

-16.00%-7.45M

20.39%-6.79M

13.40%-9.06M

-29.24%-9.95M

5.34%-33.1M

28.02%-6.42M

9.57%-8.53M

-5.55%-10.46M

-14.71%-7.7M

Investing cash flow

Cash flow from continuing investing activities

-27,816.67%-1.68M

-103.45%-361K

99.47%-56K

-1.26M

Net PPE purchase and sale

--0

-1,183.33%-77K

--0

---3K

---74K

--0

Net intangibles purchase and sale

--0

---1.6M

---361K

---53K

---1.18M

--0

Cash from discontinued investing activities

Investing cash flow

--0

-27,816.67%-1.68M

-103.45%-361K

99.47%-56K

---1.26M

--0

Financing cash flow

Cash flow from continuing financing activities

47.65%34.23M

550.18%10.65M

-86.11%1.41M

3.42%3.36M

130.81%18.81M

-47.24%23.18M

-47.52%1.64M

3,022.15%10.15M

-66.27%3.25M

-73.60%8.15M

Net issuance payments of debt

-102.58%-100K

-377.78%-50K

--0

-67.76%236K

63.43%-286K

-57.20%3.88M

-96.94%18K

667.88%3.91M

670.53%732K

-108.63%-782K

Net common stock issuance

56.88%32.1M

320.52%11.25M

-77.03%1.43M

-36.72%1.55M

96.10%17.87M

-39.06%20.46M

-17.15%2.68M

701.80%6.22M

-74.82%2.45M

-54.05%9.11M

Net preferred stock issuance

--611K

--0

----

--0

----

Proceeds from stock option exercised by employees

--1.24M

--1K

--0

----

--0

----

Net other financing activities

132.87%380K

47.54%-554K

-211.11%-20K

-563.33%-278K

792.13%1.23M

-58.14%-1.16M

-51.72%-1.06M

-93.59%18K

122.56%60K

-256.00%-178K

Cash from discontinued financing activities

Financing cash flow

47.65%34.23M

550.18%10.65M

-86.11%1.41M

3.42%3.36M

130.81%18.81M

-47.24%23.18M

-47.52%1.64M

2,620.38%10.15M

-66.10%3.25M

-73.60%8.15M

Net cash flow

Beginning cash position

-67.93%5.47M

-69.45%3.23M

-4.29%8.63M

-17.70%14.37M

-67.93%5.47M

110.77%17.05M

-14.66%10.56M

-71.75%9.01M

-45.87%17.46M

110.77%17.05M

Current changes in cash

108.49%985K

162.16%3.2M

-444.49%-5.38M

32.71%-5.7M

1,848.57%8.87M

-229.43%-11.6M

-210.05%-5.15M

108.00%1.56M

-2,405.62%-8.47M

-98.12%455K

Effect of exchange rate changes

-6.25%15K

-18.52%44K

-33.33%-20K

-251.85%-41K

164.00%32K

--16K

--54K

---15K

--27K

---50K

End cash Position

18.28%6.47M

-69.45%3.23M

-4.29%8.63M

-17.70%14.37M

-67.93%5.47M

-14.66%10.56M

-71.75%9.01M

-45.87%17.46M

Free cash flow

4.42%-33.24M

-9.83%-7.45M

20.91%-6.79M

22.70%-9.06M

-29.24%-9.95M

0.56%-34.78M

23.97%-6.78M

8.98%-8.59M

-18.18%-11.72M

-14.71%-7.7M

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-0.42%-33.24M	-16.00%-7.45M	20.39%-6.79M	13.40%-9.06M	-29.24%-9.95M	5.34%-33.1M	28.02%-6.42M	9.57%-8.53M	-5.55%-10.46M	-14.71%-7.7M
Net income from continuing operations	14.68%-41.87M	-2.63%-9.15M	36.66%-7.99M	-28.95%-12.11M	30.47%-12.63M	6.70%-49.08M	37.76%-8.91M	-3.42%-12.61M	33.31%-9.39M	-51.25%-18.16M
Operating gains losses	-266.71%-3.65M	1,000.00%9K	-369,300.00%-3.69M	100.96%6K	-98.90%31K	-10.22%2.19M	---1K	--1K	-465.12%-628K	24.34%2.82M
Depreciation and amortization	4.19%2.39M	-1.83%591K	6.47%625K	-4.17%621K	21.10%551K	26.42%2.29M	25.94%602K	24.10%587K	50.35%648K	5.57%455K
Other non cash items	6.33%13.38M	-45.31%1.72M	124.06%7.09M	10.36%3.13M	-58.12%1.44M	142.55%12.58M	103.90%3.14M	159.69%3.16M	130.25%2.84M	187.40%3.44M
Change In working capital	-150.65%-11.1M	-43.51%-3.33M	-2,221.58%-5.6M	53.86%-2M	-107.28%-179K	-295.32%-4.43M	-220.59%-2.32M	63.54%-241K	-621.45%-4.33M	1,305.71%2.46M
-Change in receivables	170.78%298K	-1,145.16%-324K	28.16%-296K	-168.71%-112K	607.39%1.03M	-117.43%-421K	-49.18%31K	-120.92%-412K	-90.70%163K	85.15%-203K
-Change in inventory	-1.93%-2.17M	-91.49%-810K	-179.86%-115K	122.50%420K	-7,645.45%-1.66M	-0.28%-2.12M	-9.30%-423K	112.96%144K	-221.34%-1.87M	156.41%22K
-Change in prepaid assets	-221.22%-5.01M	-668.81%-2.39M	2,079.66%1.17M	-113.79%-3.63M	-131.56%-160K	-95.98%-1.56M	-154.28%-311K	44.34%-59K	-176.38%-1.7M	178.12%507K
-Change in payables and accrued expense	-802.95%-3.81M	112.22%288K	-2,475.19%-6.22M	207.68%1.44M	-68.54%682K	-83.02%542K	-208.32%-2.36M	118.32%262K	100.43%469K	-1.99%2.17M
-Change in other current assets	96.91%-17K	-99.64%3K	95.51%-4K	100.15%2K	-260.00%-18K	-34.80%-550K	289.89%845K	---89K	---1.3M	-127.78%-5K
-Change in other current liabilities	-25.08%-394K	9.62%-94K	-43.68%-125K	-28.42%-122K	-82.76%-53K	-1,557.89%-315K	-89.09%-104K	-611.76%-87K	-600.00%-95K	---29K
Cash from discontinued investing activities
Operating cash flow	-0.42%-33.24M	-16.00%-7.45M	20.39%-6.79M	13.40%-9.06M	-29.24%-9.95M	5.34%-33.1M	28.02%-6.42M	9.57%-8.53M	-5.55%-10.46M	-14.71%-7.7M
Investing cash flow
Cash flow from continuing investing activities	0	0	0	0	0	-27,816.67%-1.68M	-103.45%-361K	99.47%-56K	-1.26M	0
Net PPE purchase and sale	--0	--0	--0	--0	--0	-1,183.33%-77K	--0	---3K	---74K	--0
Net intangibles purchase and sale	--0	--0	--0	--0	--0	---1.6M	---361K	---53K	---1.18M	--0
Cash from discontinued investing activities
Investing cash flow	--0	--0	--0	--0	--0	-27,816.67%-1.68M	-103.45%-361K	99.47%-56K	---1.26M	--0
Financing cash flow
Cash flow from continuing financing activities	47.65%34.23M	550.18%10.65M	-86.11%1.41M	3.42%3.36M	130.81%18.81M	-47.24%23.18M	-47.52%1.64M	3,022.15%10.15M	-66.27%3.25M	-73.60%8.15M
Net issuance payments of debt	-102.58%-100K	-377.78%-50K	--0	-67.76%236K	63.43%-286K	-57.20%3.88M	-96.94%18K	667.88%3.91M	670.53%732K	-108.63%-782K
Net common stock issuance	56.88%32.1M	320.52%11.25M	-77.03%1.43M	-36.72%1.55M	96.10%17.87M	-39.06%20.46M	-17.15%2.68M	701.80%6.22M	-74.82%2.45M	-54.05%9.11M
Net preferred stock issuance	--611K	--0	--0	----	----	--0	--0	--0	----	----
Proceeds from stock option exercised by employees	--1.24M	--1K	--0	----	----	--0	--0	--0	----	----
Net other financing activities	132.87%380K	47.54%-554K	-211.11%-20K	-563.33%-278K	792.13%1.23M	-58.14%-1.16M	-51.72%-1.06M	-93.59%18K	122.56%60K	-256.00%-178K
Cash from discontinued financing activities
Financing cash flow	47.65%34.23M	550.18%10.65M	-86.11%1.41M	3.42%3.36M	130.81%18.81M	-47.24%23.18M	-47.52%1.64M	2,620.38%10.15M	-66.10%3.25M	-73.60%8.15M
Net cash flow
Beginning cash position	-67.93%5.47M	-69.45%3.23M	-4.29%8.63M	-17.70%14.37M	-67.93%5.47M	110.77%17.05M	-14.66%10.56M	-71.75%9.01M	-45.87%17.46M	110.77%17.05M
Current changes in cash	108.49%985K	162.16%3.2M	-444.49%-5.38M	32.71%-5.7M	1,848.57%8.87M	-229.43%-11.6M	-210.05%-5.15M	108.00%1.56M	-2,405.62%-8.47M	-98.12%455K
Effect of exchange rate changes	-6.25%15K	-18.52%44K	-33.33%-20K	-251.85%-41K	164.00%32K	--16K	--54K	---15K	--27K	---50K
End cash Position	18.28%6.47M	18.28%6.47M	-69.45%3.23M	-4.29%8.63M	-17.70%14.37M	-67.93%5.47M	-67.93%5.47M	-14.66%10.56M	-71.75%9.01M	-45.87%17.46M
Free cash flow	4.42%-33.24M	-9.83%-7.45M	20.91%-6.79M	22.70%-9.06M	-29.24%-9.95M	0.56%-34.78M	23.97%-6.78M	8.98%-8.59M	-18.18%-11.72M	-14.71%-7.7M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall